NasdaqGS:OMCLMedical Equipment
Omnicell (OMCL): Return to Profitability Reinforces Bullish Narrative as Margins and Earnings Forecasts Improve
Omnicell (OMCL) has turned profitable over the past year after a period of declining earnings. Profits are forecast to rise roughly 63.9% annually and revenue is expected to grow by 3.9% per year. Its net profit margins have improved and earnings quality is described as high. The current share price of $33.60 sits below an independent fair value estimate of $41.26, hinting at undervaluation despite a lofty 66.8x P/E ratio versus peers. With the balance of risks tilted towards rewards and...